Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 200, No. 2, 2000   

Free Abstract     Article (Fulltext)     Article (PDF 276 KB)     

Pharmacology and Treatment

Treatment of Old World Cutaneous Leishmaniasis by Pentamidine Isethionate
An Open Study of 11 Patients
Isabelle Helliera, Olivier Dereurea, Isabelle Tournillacc, Francine Pratlongb, Bernard Guillotc, Jean-Pierre Dedetb, Jean-Jacques Guilhoua

aDepartment of Dermatology-Phlebology and
bLaboratory of Parasitology, CHRU Montpellier, and
cDepartment of Dermatology, CHRU Nîmes, France

Address of Corresponding Author

Dermatology 2000;200:120-123 (DOI: 10.1159/000018343)


 goto top of page Key Words

  • Leishmaniasis
  • Isethionate pentamidine

 goto top of page Abstract

Background: Pentavalent antimonial derivatives (PAD), especially meglumine antimoniate (Glucantime®), are usually considered as the first-line drugs for Old World leishmaniasis, but their potential toxicity and the number of required injection, either intralesional or intramuscular, prompt to search for alternative treatments. Objective: To evaluate the efficiency and tolerance of pentamidine isethionate in Old World leishmaniasis. Methods: An open pilot study included 11 patients from two regional academic centers, with varied parasitological forms of Old World leishmaniasis, treated with three strictly intramuscular injections of 4 mg/kg of base-pentamidine every other day. Results: Tolerance was good overal, and 8/11 (73%) of patients responded well with a quick healing of their lesions, little scarring and no relapse. Conclusion: Pentamidine isethionate is a safe and effective first-line treatment for Old World leishmaniasis. Larger-scale prospective studies comparing several dosage regimens of pentamidine and pentamidine isethionate to PAD are warranted.

Copyright © 2000 S. Karger AG, Basel


 goto top of page Author Contacts

O. Dereure
Department of Dermatology-Phlebology, Hôpital Saint-Eloi
2, avenue B.-Sans, F-34295 Montpellier Cedex 5 (France)
Tel. +33 467 33 69 06, Fax +33 467 54 23 80
E-Mail ofdereure@wanadoo.fr


 goto top of page Article Information

Received: Received: September 20, 1999
Accepted: October 21, 1999
Number of Print Pages : 4
Number of Figures : 2, Number of Tables : 0, Number of References : 8

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 10773699)
Download Citation




For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their research paper editing service.




copyright  © 2008 S. Karger AG, Basel